| Tricia E Albert, OTR/L | |
|
39 Limerick Rd, Arundel, ME 04046-8158 | |
| (207) 985-1861 | |
| Not Available |
| Full Name | Tricia E Albert |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 39 Limerick Rd, Arundel, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366744302 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT815 (Maine) | Primary |
| Provider Name | Healthpro Heritage Rehab & Fitness Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1861131377 PECOS PAC ID: 6507832573 Enrollment ID: O20220728002141 |
News Archive
NxStage Medical, Inc. is encouraging patients to take control of their dialysis therapy and consider home hemodialysis in the wake of a new study that found patient survivability rates are significantly higher with home hemodialysis (HHD) than peritoneal dialysis (PD).
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
The new product planning and development process is fraught with challenges, from regulatory requirements and safety concerns to cost constraints and competitive pressures. New product planning leaders looking to safeguard their new products' success in 2012 and beyond need an updated road map to help guide them through the new clinical development landscape.
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).
Researchers say that women who have IVF treatment are more likely to suffer a potentially life-threatening condition than those who conceive naturally.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tricia E Albert, OTR/L 19 Sage Brush Dr, Scarborough, ME 04074-9165 Ph: (207) 808-9253 | Tricia E Albert, OTR/L 39 Limerick Rd, Arundel, ME 04046-8158 Ph: (207) 985-1861 |
News Archive
NxStage Medical, Inc. is encouraging patients to take control of their dialysis therapy and consider home hemodialysis in the wake of a new study that found patient survivability rates are significantly higher with home hemodialysis (HHD) than peritoneal dialysis (PD).
EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.
The new product planning and development process is fraught with challenges, from regulatory requirements and safety concerns to cost constraints and competitive pressures. New product planning leaders looking to safeguard their new products' success in 2012 and beyond need an updated road map to help guide them through the new clinical development landscape.
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).
Researchers say that women who have IVF treatment are more likely to suffer a potentially life-threatening condition than those who conceive naturally.
› Verified 1 days ago
Jessica Cormier, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Limerick Rd, Arundel, ME 04046 Phone: 207-985-7861 Fax: 207-985-6703 | |
River Birch Occupational Therapy Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1236 Portland Rd, Arundel, ME 04046 Phone: 207-468-1293 | |
Kimberly Marion, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Limerick Rd, Arundel, ME 04046 Phone: 207-985-7861 Fax: 207-985-6703 | |
Ms. Lauren Patricia Bicknell, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Limerick Rd, Arundel, ME 04046 Phone: 207-735-8749 | |
Mrs. Kelly Weber, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Limerick Rd, Arundel, ME 04046 Phone: 207-985-7861 | |
Ms. Kristin Winston, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 39 Limerick Rd, Arundel, ME 04046 Phone: 207-985-7861 Fax: 207-985-6703 | |
Lorie B Wyman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1236 Portland Rd, Arundel, ME 04046 Phone: 207-468-1293 |